Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis

Clinical trial NCT00619957 · COMPLETED

Trial details

NCT number: NCT00619957
Sponsor: Warner Chilcott
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Other Osteoporosis

Start date: 2002-06-01
Primary completion: 2007-05-01
Enrollment: 285

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.